Researchers have demonstrated that lipid nanoparticles can package and deliver an entire therapeutic gene along with ...

Eli Lilly (NYSE:LLY) reported successful results from the TOGETHER-PsO Phase 3b trial combining Taltz and Zepbound for patients with psoriasis and obesity. The company reached a second key milestone ...

Crispr’s ability to cut genetic code like scissors has just started to turn into medicines. Now, gene editing pioneer Jennifer Doudna wants to build an entire ecosystem to bring these treatments ...

Faced with a life-threatening metabolic disease, KJ’s doctors at Children’s Hospital of Philadelphia sprinted to create a ...

Scientists are testing an entirely new way to fight heart disease: whether gene editing might offer a one-time fix for high cholesterol.

A research team has successfully demonstrated the world's first gene-editing treatment for Leber's hereditary optic ...

The idea of self-amplifying gene editing is to get cells to pass on packages of CRISPR machinery to their neighbours, boosting the effect ...

Eli Lilly (NYSE:LLY) reached a second milestone in its CRISPR gene editing collaboration with Scribe Therapeutics, advancing programs in neurological and neuromuscular diseases. The company reported ...

The Canadian government's recent approval of the first gene-edited animal to enter the food system has reignited debates over ...

Scientists are testing an entirely new way to fight heart disease: a gene-editing treatment that might offer a one-time ...

UCLA researchers have developed a lipid nanoparticle-based gene-editing approach capable of inserting an entire healthy gene ...